scholarly journals Seroprevalence of Human Herpesvirus 8 and Hepatitis C Virus among Drug Users in Shanghai, China

Viruses ◽  
2014 ◽  
Vol 6 (6) ◽  
pp. 2519-2530 ◽  
Author(s):  
Tiejun Zhang ◽  
Ying Liu ◽  
Yuyan Zhang ◽  
Jun Wang ◽  
Veenu Minhas ◽  
...  
2003 ◽  
Vol 348 (2) ◽  
pp. 178-179 ◽  
Author(s):  
Sylvie Hermouet ◽  
Isabelle Corre ◽  
Michelle Gassin ◽  
Edith Bigot-Corbel ◽  
Claudia A. Sutton ◽  
...  

2004 ◽  
Vol 77 (4) ◽  
pp. 419-420 ◽  
Author(s):  
Toshitatsu Takao ◽  
Yutaka Kobayashi ◽  
Junya Kuroda ◽  
Atsusi Omoto ◽  
Tomoko Nishimura ◽  
...  

Sexual Health ◽  
2016 ◽  
Vol 13 (3) ◽  
pp. 295 ◽  
Author(s):  
Rezvan Kakavand-Ghalehnoei ◽  
Zabihollah Shoja ◽  
Alireza Najafi ◽  
Mostafa Haji Mollahoseini ◽  
Shohreh Shahmahmoodi ◽  
...  

Studies looking at the frequency of human herpesvirus-8 (HHV-8) among Iranian blood donors have produced conflicting results. The aim of this study was to investigate the prevalence of HHV-8 DNA by using polymerase chain reaction methods among 168 healthy individuals, 60 intravenous drug users and 100 HIV-infected patients from Iran. The prevalence of HHV-8 was significantly higher among intravenous drug users (13.3%) compared with the general population (3.6%; P = 0.017). The HHV-8 genome was mostly detected among intravenous drug users who displayed high-risk sexual behaviours. Moreover, the HHV-8 genome was also detected in 8% of HIV-infected patients. The present study findings support the likelihood that the transmission of HHV-8 is via a sexual route in the Iranian population.


2003 ◽  
Vol 187 (6) ◽  
pp. 974-981 ◽  
Author(s):  
Jonnae Atkinson ◽  
Brian R. Edlin ◽  
Eric A. Engels ◽  
Alex H. Kral ◽  
Karen Seal ◽  
...  

2009 ◽  
Vol 138 (3) ◽  
pp. 403-408 ◽  
Author(s):  
A. ZAVITSANOU ◽  
M. MALLIORI ◽  
V. SYPSA ◽  
M. PETRODASKALAKI ◽  
M. PSICHOGIOU ◽  
...  

SUMMARYA cross-sectional study was carried out in injecting drug users (IDUs) from Greece to assess the seroprevalence of human herpesvirus 8 (HHV-8) and to identify potentially associated risk factors. A total of 288 IDUs were tested for K8.1 antibodies to HHV-8 lytic antigen. Associations between HHV-8 serostatus and potential risk factors were examined using univariate and multivariate logistic regression analysis. Seroprevalence of HHV-8 was 24·3% (95% CI 19·5–29·7), increasing with age from 19·4% in those aged <30 years to 52·9% in those aged ⩾40 years (Pfor trend=0·003). No statistically significant associations between HHV-8-positive status and gender, educational level, age at first drug injection, needle sharing, number of imprisonments, complications from drug overdose, HIV and HCV were observed. In the multivariate logistic regression analysis, older age (⩾40vs. <40 years, OR 3·30, 95% CI 1·14–9·56) and report of septicaemia/abscess (yesvs. no, OR 1·80, 95% CI 1·01–3·18) were each independently associated with higher HHV-8 seroprevalence. HHV-8 is highly prevalent in the IDU population in Greece. The independent association between HHV-8 and reported abscess or septicaemia supports the hypothesis that poor hygiene conditions in the setting of drug injection may contribute to HHV-8 transmission.


Sign in / Sign up

Export Citation Format

Share Document